Pharming Group N.V. ( PHAR) - Stock Earnings
PHAR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
PHAR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 5.3 million USD | 106.5 million USD |
| 2026Q1 | -5.2 million USD | 72.4 million USD |
| 2026Q2 | 1.6 million USD | 90.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PHAR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.5 million USD | 245.3 million USD |
| 2024 | -12.3 million USD | 307.7 million USD |
| 2025 | 2.9 million USD | 376.1 million USD |
| 2026 Est. | — | — |
PHAR
Price: $10.85
Earnings Per Share: 0.15 USD
P/E Ratio: 68.40
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 1500
Market Capitalization: 691.5 million